v3.25.2
SEGMENT AND GEOGRAPHIC INFORMATION - Segment Reporting Information (Details) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Segment Reporting Information [Line Items]          
Total revenue, net $ 415,605,000 $ 418,175,000 $ 798,258,000 $ 787,047,000  
Cost of goods sold 206,273,000 192,258,000 394,494,000 354,296,000  
Research and development 26,997,000 29,767,000 51,725,000 56,732,000  
Selling, general & administrative 179,890,000 195,472,000 361,387,000 361,270,000  
Intangible asset amortization 3,754,000 3,707,000 7,458,000 13,814,000  
Goodwill impairment 511,365,000 0 511,365,000 0 $ 0
Total costs and expenses 928,279,000 421,204,000 1,326,429,000 786,112,000  
Operating (loss) income (512,674,000) (3,029,000) (528,171,000) 935,000  
Interest income 4,710,000 5,058,000 9,130,000 10,098,000  
Interest expense (21,042,000) (18,651,000) (39,857,000) (32,275,000)  
Other income, net (1,946,000) 1,437,000 (2,090,000) 827,000  
Loss before income taxes (530,952,000) (15,185,000) (560,988,000) (20,415,000)  
Codman Specialty Surgical          
Segment Reporting Information [Line Items]          
Total revenue, net 303,958,000 301,761,000 584,622,000 558,195,000  
Tissue Technologies          
Segment Reporting Information [Line Items]          
Total revenue, net 111,647,000 116,414,000 213,636,000 228,852,000  
Operating Segments | Codman Specialty Surgical          
Segment Reporting Information [Line Items]          
Total revenue, net 303,958,000 301,761,000 584,622,000 558,195,000  
Cost of goods sold 102,004,000 92,640,000 194,781,000 185,613,000  
Research and development 7,698,000 7,567,000 15,643,000 13,332,000  
Selling, general & administrative 69,202,000 37,413,000 138,877,000 91,617,000  
Intangible asset amortization 0 0 0 0  
Goodwill impairment 388,106,000 0 388,106,000 0  
Total costs and expenses 567,010,000 137,620,000 737,407,000 290,562,000  
Operating (loss) income (263,052,000) 164,141,000 (152,785,000) 267,633,000  
Operating Segments | Tissue Technologies          
Segment Reporting Information [Line Items]          
Total revenue, net 111,647,000 116,414,000 213,636,000 228,852,000  
Cost of goods sold 50,768,000 41,444,000 95,830,000 78,983,000  
Research and development 4,334,000 4,451,000 8,054,000 9,351,000  
Selling, general & administrative 38,317,000 33,332,000 74,805,000 72,665,000  
Intangible asset amortization 0 0 0 0  
Goodwill impairment 123,259,000 0 123,259,000 0  
Total costs and expenses 216,678,000 79,227,000 301,948,000 160,999,000  
Operating (loss) income (105,031,000) 37,187,000 (88,312,000) 67,853,000  
Corporate and Other          
Segment Reporting Information [Line Items]          
Total revenue, net 0 0 0 0  
Cost of goods sold 53,501,000 58,174,000 103,883,000 89,700,000  
Research and development 14,965,000 17,749,000 28,028,000 34,049,000  
Selling, general & administrative 72,371,000 124,727,000 147,705,000 196,988,000  
Intangible asset amortization 3,754,000 3,707,000 7,458,000 13,814,000  
Goodwill impairment 0 0 0 0  
Total costs and expenses 144,591,000 204,357,000 287,074,000 334,551,000  
Operating (loss) income $ (144,591,000) $ (204,357,000) $ (287,074,000) $ (334,551,000)